SFS
GBT

Sowell Financial Services’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Sowell Financial Services’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-702
Closed -$27K – 3064
2021
Q1 		$27K Sell
702
-10
-1% -$460 ﹤0.01% 1930
2020
Q4 		$31K Buy
712
+200
+39% +$9.86K ﹤0.01% 1573
2020
Q3 		$28K Sell
512
-50
-9% -$3.18K ﹤0.01% 1420
2020
Q2 		$35K Buy
562
+102
+22% +$7K ﹤0.01% 1286
2020
Q1 		$24K Sell
460
-330
-42% -$22.1K ﹤0.01% 1336
2019
Q4 		$63K Buy
+790
New +$46.8K ﹤0.01% 1076

Other funds holding GBT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Sowell Financial Services's GBT Position: Q2 2021 in Review

Sowell Financial Services sold out of Global Blood Therapeutics, Inc. (GBT) in Q2 2021, closing a stake of 702 shares — an estimated $27K sold.

Sowell Financial Services first reported a position in GBT in Q4 2019 and held it in 6 quarters. The position peaked at $63K in Q4 2019. 191 funds tracked by Wall St. Rank hold GBT as of Q2 2021.

  • Sowell Financial Services reported no remaining Global Blood Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 702 Global Blood Therapeutics, Inc. shares in Q2 2021, an estimated $27K.
  • Sowell Financial Services first reported a position in Global Blood Therapeutics, Inc. in Q4 2019 and held it in 6 quarters.
  • Sowell Financial Services's Global Blood Therapeutics, Inc. position peaked at $63K in Q4 2019.
  • 191 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.